DURHAM, N.C. -- The review process being used by the Food and Drug Administration to assess the safety of a faster-growing transgenic salmon fails to weigh the full effects of the fish's widespread production, according to analysis by a Duke University-led team in this week's Science.
The salmon, whose genome contains inserted genes from two other fish species, could become the first genetically modified animal approved for human consumption in the United States.



